Zheng Quan Shi Bao Wang·2025-08-12 08:34Market Overview - The recombinant protein sector experienced a decline of 1.14%, ranking among the top losers in the concept sector as of the market close on August 12 [1] - Notable stocks within this sector that saw significant declines include HaiTe Bio, Kexing Pharmaceutical, and Huiyu Pharmaceutical, while 13 stocks recorded gains, with *ST WanFang, Zhenghai Bio, and Huabei Pharmaceutical leading the increases at 3.42%, 2.66%, and 2.08% respectively [1] Capital Flow - The recombinant protein sector faced a net outflow of 484 million yuan from major funds, with 32 stocks experiencing net outflows, and 8 stocks seeing outflows exceeding 30 million yuan [1] - HaiTe Bio led the outflows with a net withdrawal of 79.69 million yuan, followed by YiPinHong, Chengdu XianDao, and BeiDa Pharmaceutical with outflows of 72.64 million yuan, 64.49 million yuan, and 52.64 million yuan respectively [1] Top Gainers and Losers - The top gainers in the recombinant protein sector included DeZhan Health, HuaXi Bio, and BoRui Pharmaceutical, with net inflows of 68.21 million yuan, 24.69 million yuan, and 17.58 million yuan respectively [3] - The detailed outflow list highlights stocks such as HaiTe Bio (-8.67%), YiPinHong (-2.70%), and Chengdu XianDao (-2.88%) as the most affected by capital withdrawal [2]